Back to all use cases

Evaluate every Ozempic and GLP-1 claim against the evidence that determines case strength.

Pattern Data gives law firms instant visibility into their entire GLP-1 docket. See which cases are strong, which need development, and where to focus resources, without manually reviewing each file.

Ozempic Dashboards Website  (1)
intake

Confirm drug exposure across your full inventory

Pattern identifies and classifies all GLP-1 product use, branded, generic, and compounded, and calculates each claimant's exposure window. Compounded use is automatically flagged, giving firms immediate visibility into the defense risk that dockets are quietly carrying.

intake

Identify qualifying injuries across both active tracks

The GLP-1 litigation has two distinct injury tracks: gastrointestinal (Gastroparesis, Ileus) and ocular (NAION). Pattern's lens is purpose-built for both, not just the primary GI track that most firms have structured their intake around.

intake

Surface the evidence the court is requiring

Following Judge Marston's August 2025 ruling, Gastroparesis claims must be supported by objective diagnostic testing, specifically a gastric emptying study. Pattern identifies exactly which claimants have the required evidence and which have a documentation gap that needs to be closed.

strategic

Score every case and prioritize your docket

Every claimant receives a Development Case Score on a 0 to 6 scale, calculated from exposure type, injury classification, use duration, hospitalization evidence, and related surgery or death. Firms can rank their entire inventory in seconds.

What Pattern evaluates in every GLP-1 claim.

Ensure each Ozempic case meets settlement criteria with thorough documentation and analysis.

GLP-1 product exposure and duration

Qualifying injuries across the GI and vision loss tracks

Diagnostic testing requirements, including gastric emptying study results

Hospitalization, ER visits, surgery, and related death

Defense risk factors including diabetes history, prior surgeries, and smoking history

Compounded GLP-1 use and its impact on claim viability

Generate claimant profiles

Pattern extracts and organizes data from medical records into structured claimant profiles, giving your team a clear view of exposure, injury, diagnostic testing, and treatment evidence for every case in your inventory.

Ozempic Claimant Profile

Understand your GLP-1 inventory instantly

Interactive dashboards show case strength distribution, documentation gaps, and issue severity across your full docket, so your team knows where to focus without pulling individual files.

Ozempic Dashboards Website  (1)

Reviewer Guidance built into every profile

Pattern surfaces contextual flags directly within each claimant profile, identifying missing dates, unconfirmed diagnoses, documentation gaps, and timeline discrepancies, so reviewers always know what needs attention and why.

Ozempic  Reviewer Guidance

Generate claimant work product

Export structured case data including development scores, supporting evidence, and medical records in a format ready for attorney review and case development.

Ozempic_Web_Export

How law firms use pattern data.

At Pattern Data, we ensure the latest security technologies and procedures are in place to keep your clients’ information safe. Here are some of the steps we take to safeguard your data.

Mass transfer records for fast analysis

Process large caseloads quickly using our advanced data processing, tailored specifically for Ozempic litigation.

Advanced OCR technology

Convert unstructured medical data into structured, actionable information tailored to Ozempic settlement criteria.

Automated recalculations

Easily adapt to new settlement criteria or injury updates with our system’s automated recalculations and export features.

Seamless integration and customization

Integrate with existing processes seamlessly, using customizable scripts, automated actions, and workflow settings to optimize efficiency.